Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cellegy adds board member; former executive with J & J, American Cyanamid and CIBA-GEIGY.


FOSTER CITY, Calif.--(BUSINESS WIRE)--Dec. 17, 1996--Cellegy Pharmaceuticals Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:CLGY)(Warrants:CLGYW) Tuesday said it added Jack L. Bowman to the company's board of directors.

Bowman has more than 30 years executive experience with some of the world's largest pharmaceutical companies. From 1987 to 1994, he was group chairman at Johnson & Johnson, where he managed J & J's $2 billion global pharmaceutical business.

For the seven years prior, Bowman held a series of executive positions with American Cyanamid American Cyanamid was a large, diversified, American chemical manufacturer. Lederle Laboratories, maker of Centrum and Stresstabs vitamins, was Cyanamid's pharmaceutical division. Davis & Geck was the company's medical device division. , culminating as executive vice president responsible for the company's worldwide pharmaceutical, medical device, cosmetic and toiletry divisions.

From 1959 to 1980, Bowman was employed by CIBA-GEIGY, where he held various sales, marketing and executive positions in the company's pharmaceutical business.

Commenting on the appointment, Cellegy President and Chief Executive K. Michael Forrest said he was highly gratified grat·i·fy  
tr.v. grat·i·fied, grat·i·fy·ing, grat·i·fies
1. To please or satisfy: His achievement gratified his father. See Synonyms at please.

2.
 to have attracted an executive of Bowman's stature, and said he would be of "enormous value" in the achievement of the company's strategic objectives.

"Jack has precisely the high-profile background that will help Cellegy make major advances in its current commercialization phase and over the long term. We are very excited to have him with us."

Bowman holds board memberships with NeoRx Corp. and Cell Therapeutics Inc. in Seattle; CytRx Corp. in Norcross, Ga.; PharmaGenics in Allendale, N.J. ; and Burrill & Craves in San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden .

Cellegy is a pharmaceutical company developing and bringing to market, through corporate collaborations and marketing arrangements, a new generation of drug-delivery products as well as consumer and prescription products based upon manipulation of the skin barrier.

CONTACT: Cellegy Pharmaceuticals Inc., Foster City

Richard Juelis, 415/524-1600

or

Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 contacts:

Eisenberg Communications, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 

Rick Eisenberg, 212/496-6828

or

Market Makers, Santa Barbara Santa Barbara (săn'tə bär`brə, –bərə), city (1990 pop. 85,571), seat of Santa Barbara co., S Calif., on the Pacific Ocean; inc. 1850. , Calif.

Jimmy Caplan, 805/569-0076
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 17, 1996
Words:289
Previous Article:ONYX Announces Changes to its Board.
Next Article:Gretchen Eichinger joins Sega to head third party team.
Topics:



Related Articles
Garibaldi Group brokers CIBA-GEIGY division move.
Alex Krauer.
CIBA breaks ground on new lab in Tarrytown.
Ciba Specialty Chemicals.
C&W announces Summit laboratory sale.
Class action suits target Ritalin.
DRUG GIANTS TO MERGE\Ciba, Sandoz to pool biotech research efforts.
25 Halogenated flame retardants.
30 Hindered phenolic antioxidants.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles